Read more:
Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook
Category Archives: Global News Feed
Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises
Madrigal Provides Update on Timeline for Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom
Coherus BioSciences Announces CMS Has Extended Enhanced Medicare Reimbursement for UDENYCA® in the 340B Hospital Setting Through Year-End 2022
Selecta Biosciences to Host Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Business Update
BioDelivery Sciences Prevails in BELBUCA® ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032
PAOG Announces Plans To Add New Pharmaceutical Product Developments
Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes
Genovac Purchases Third Beacon® Optofluidic System and Expands its Capabilities into Cell Line Development
Monthly information related to total number of voting rights and shares composing the share capital – October 30, 2021
Eledon Pharmaceuticals Announces Upcoming Presentation on AT-1501 at the Virtual 2021 International Pancreas and Islet Transplantation Association…
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
See the original post:
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week
Bone Therapeutics Provides First Quarter 2021 Business Update
Continue reading here:
Bone Therapeutics Provides First Quarter 2021 Business Update
Prometheus Biosciences to Present at 2021 Jefferies Virtual Healthcare Conference
See the article here:
Prometheus Biosciences to Present at 2021 Jefferies Virtual Healthcare Conference
PolyPid to Report Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights on February 10, 2021
Orchard Therapeutics Announces $150 Million Strategic Financing
Read the original:
Orchard Therapeutics Announces $150 Million Strategic Financing